What are the criteria for a pathological Q (quantum) wave?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Criteria for Pathological Q Waves on ECG

Pathological Q waves are defined as any Q wave in leads V2–V3 ≥0.02 sec or QS complex in leads V2 and V3, or Q wave ≥0.03 sec and ≥0.1 mV deep or QS complex in leads I, II, aVL, aVF or V1–V6 in any two leads of a contiguous lead grouping. 1

Specific Criteria for Pathological Q Waves

  • Duration and Depth Requirements:

    • In leads V2-V3: Q wave ≥0.02 sec or QS complex
    • In leads I, II, aVL, aVF, V1-V6: Q wave ≥0.03 sec and ≥0.1 mV deep or QS complex
    • Must be present in at least two leads of a contiguous lead grouping 1
  • Lead Groupings for Assessment:

    • Anterior: V1-V4
    • Inferior: II, III, aVF
    • Lateral: V5, V6, I, aVL 1, 2

Normal Q Wave Variants (Non-Pathological)

  • QS complex in lead V1 (normal variant)
  • Q wave <25% of R wave amplitude in lead III
  • Q wave in aVL if frontal QRS axis is between 60° and 90°
  • Small septal Q waves in leads I, aVL, aVF, and V4–V6 1

Clinical Significance and Diagnostic Value

  • The "classic" criteria for Q waves show the strongest correlation with infarct size as measured by cardiac magnetic resonance imaging 3
  • Q waves reliably predict MI location, size, and transmural extent primarily in anterior infarctions 2, 4
  • Even small Q waves (<40-ms duration and <0.5-mV amplitude) in V2 or V3 significantly predict the presence of coronary artery disease, particularly left anterior descending artery stenosis 5
  • The presence of Q waves is determined more by total infarct size than by transmural extent 4

Special Considerations

  • Population-Specific Variations:

    • In adolescents <16 years, borderline Q waves in anterior leads may represent a normal "juvenile pattern"
    • In Black athletes, borderline Q waves in anterior leads may be a normal variant, especially with J-point elevation and convex ST-segment elevation
    • Pathological Q waves are reported in approximately 1-2% of all athletes, with higher prevalence in males and Black athletes 1
  • Potential Pitfalls:

    • Lead misplacement, especially in V1-V2, can result in false positives
    • Isolated Q waves in lead III may be normal, especially without repolarization abnormalities
    • Q waves in multiple inferior leads warrant investigation as they cannot be attributed to physiological remodeling 1

Non-Ischemic Causes of Q Waves

  • Cardiomyopathy (hypertrophic, dilated, stress, cardiac amyloidosis)
  • Conduction disturbances (LBBB, left anterior hemiblock, pre-excitation syndromes, ventricular pacing)
  • Ventricular hypertrophy (left and right)
  • Myocarditis
  • Acute cor pulmonale
  • Hyperkalemia 1

Evaluation Approach for Q Waves

  1. Apply pathological criteria (duration, depth, distribution)
  2. Consider clinical context and patient demographics
  3. Evaluate for normal variants based on lead location and patient characteristics
  4. For borderline or concerning Q waves:
    • Perform echocardiography (minimum evaluation)
    • Consider cardiac MRI if echocardiogram is normal but clinical suspicion remains
    • Consider stress testing for patients ≥30 years with risk factors for CAD 1

The use of Q/R ratio helps normalize Q wave depth to the degree of proceeding R-wave voltage, which can reduce false positives in athletes with physiological left ventricular hypertrophy 1.

References

Guideline

Interpretation of Q Waves on ECG

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diagnostic significance of a small Q wave in precordial leads V(2) or V(3).

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.